Drug class
Ophthalmic Antiallergic Agents
Ophthalmic antiallergic agents are a broad therapeutic class of topical ocular medications formulated to treat acute and chronic hypersensitivity reactions of the eye. Read more about Ophthalmic Antiallergic Agents
100 drugs in this class 45 manufacturers
Drugs in Ophthalmic Antiallergic Agents
WAL-ZYR (KETOTIFEN) (ketotifen fumarate)
EYE ALLERGY ITCH-REDNESS RLF (olopatadine HCl)
EYE ALLERGY ITCH RELIEF (olopatadine HCl)
LASTACAFT ONCE DAILY RELIEF (alcaftadine)
OPCON-A (naphazoline HCl/pheniramine maleate)
EYE ALLERGY RELIEF (naphazoline HCl/pheniramine maleate)
ADVANCED EYE RELIEF (glycerin/propylene glycol)
ALAWAY (ketotifen fumarate)
Ophthalmic antiallergic agents are a broad therapeutic class of topical ocular medications formulated to treat acute and chronic hypersensitivity reactions of the eye.
They encompass several pharmacologic groups, including histamine receptor antagonists, mast cell stabilizers, and dual-acting antihistamine/mast cell stabilizing agents, with selective adjuncts including vasoconstrictors, ocular NSAIDs, and corticosteroids.
These agents work by preventing mast cell degranulation, blocking histamine-mediated vascular permeability, and suppressing the inflammatory cascade to relieve ocular pruritus, hyperemia, and conjunctival edema.
Their primary clinical applications are in the management of seasonal and perennial allergic conjunctivitis, as well as more severe forms of ocular allergy such as vernal and atopic keratoconjunctivitis.
-
nih.gov
Ophthalmic antiallergic agents are a broad therapeutic class of topical ocular medications formulated to treat acute and chronic hypersensitivity reactions of the eye They encompass several pharmacologic groups, including histamine receptor antagonists, mast cell stabilizers, and dual-acting antihistamine/mast cell stabilizing agents, with selective adjuncts including vasoconstrictors, ocular NSAIDs, and corticosteroids
-
nih.gov
Ophthalmic antiallergic agents are a broad therapeutic class of topical ocular medications formulated to treat acute and chronic hypersensitivity reactions of the eye Their primary clinical applications are in the management of seasonal and perennial allergic conjunctivitis, as well as more severe forms of ocular allergy such as vernal and atopic keratoconjunctivitis
-
aaaai.org
They encompass several pharmacologic groups, including histamine receptor antagonists, mast cell stabilizers, and dual-acting antihistamine/mast cell stabilizing agents, with selective adjuncts including vasoconstrictors, ocular NSAIDs, and corticosteroids
-
nih.gov
These agents work by preventing mast cell degranulation, blocking histamine-mediated vascular permeability, and suppressing the inflammatory cascade to relieve ocular pruritus, hyperemia, and conjunctival edema
-
orpdl.org
These agents work by preventing mast cell degranulation, blocking histamine-mediated vascular permeability, and suppressing the inflammatory cascade to relieve ocular pruritus, hyperemia, and conjunctival edema
-
nih.gov
Their primary clinical applications are in the management of seasonal and perennial allergic conjunctivitis, as well as more severe forms of ocular allergy such as vernal and atopic keratoconjunctivitis
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.